Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM872 in Acute Ischemic Stroke
NCT00044070Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2000
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of zonampanel in ischemic stroke, sponsored by Astellas Pharma. Started Dec 2000; status: completed.
02
Drugs
zonampanel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00044070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044070.